CRISPR Therapeutics AG - Common Stock (CRSP)

Historical Holders from Q1 2016 to Q1 2025

Symbol
CRSP on Nasdaq
CUSIP
H17182108
Type / Class
Equity / Common Stock
Shares outstanding
85.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
64.4M
Holdings value
$2.54B
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
398
Number of buys
154
Number of sells
-184
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CRISPR Therapeutics AG - Common Stock (CRSP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARK Investment Management LLC 10.51% $377M 8.97M ARK Investment Management LLC Dec 31, 2024

Institutional Holders of CRISPR Therapeutics AG - Common Stock (CRSP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 650K $22.4M +$2.07M $34.03 57
2024 Q4 64.4M $2.54B +$195M $39.36 398
2024 Q3 59.4M $2.79B -$17.8M $46.98 407
2024 Q2 59.5M $3.21B +$82.3M $54.01 442
2024 Q1 56.7M $3.86B +$140M $68.16 472
2023 Q4 55.5M $3.48B +$76.5M $62.60 460
2023 Q3 54.4M $2.47B -$2.32M $45.39 395
2023 Q2 54M $3.03B -$106M $56.14 402
2023 Q1 56.1M $2.54B +$37.9M $45.23 369
2022 Q4 55.4M $2.25B -$39.6M $40.65 378
2022 Q3 53.7M $3.5B -$158M $65.35 401
2022 Q2 54.9M $3.31B +$273M $60.77 399
2022 Q1 48.7M $3.06B +$484M $62.77 406
2021 Q4 41.9M $3.18B +$68.8M $75.78 417
2021 Q3 39.3M $4.4B -$50.8M $111.93 458
2021 Q2 40.6M $6.57B -$213M $161.89 489
2021 Q1 43M $5.2B -$577M $121.85 431
2020 Q4 47.2M $7.22B +$35M $153.11 391
2020 Q3 47.9M $4B +$725M $83.64 296
2020 Q2 37.5M $2.76B +$288M $73.49 259
2020 Q1 35.4M $1.5B +$147M $42.41 239
2019 Q4 31.5M $1.92B +$255M $60.90 242
2019 Q3 27.4M $1.13B -$8.94M $40.99 173
2019 Q2 27.3M $1.28B +$105M $47.10 174
2019 Q1 25.9M $926M +$146M $35.72 161
2018 Q4 22.1M $631M -$52.6M $28.57 149
2018 Q3 22.8M $1.01B +$171M $44.35 168
2018 Q2 18.1M $1.06B +$2.99M $58.76 168
2018 Q1 18.7M $855M +$304M $45.71 131
2017 Q4 12.5M $293M +$61.8M $23.48 81
2017 Q3 10M $179M +$6.2M $17.87 59
2017 Q2 9.68M $155M -$3.83M $16.02 33
2017 Q1 9.69M $210M -$3.15M $21.76 34
2016 Q4 9.83M $198M +$198M $20.26 26
2016 Q1 40 $1K $0 $25.00 1